UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027870
Receipt number R000031933
Scientific Title Sonoclot and TEG6s guided transfusion therapy for preoperative point of care monitoring
Date of disclosure of the study information 2017/06/23
Last modified on 2021/06/26 09:29:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Sonoclot and TEG6s guided transfusion therapy for preoperative point of care monitoring

Acronym

Sonoclot and TEG6s guided transfusion therapy for preoperative point of care monitoring

Scientific Title

Sonoclot and TEG6s guided transfusion therapy for preoperative point of care monitoring

Scientific Title:Acronym

Sonoclot and TEG6s guided transfusion therapy for preoperative point of care monitoring

Region

Japan


Condition

Condition

The patients who are planned to undergone open heart surgery

Classification by specialty

Anesthesiology Cardiovascular surgery Operative medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purposes are the establishment to appropriate utilization to blood products and point of care monitoring guided transfusion therapy which is quick and high reliable.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the numbers of order of fresh frozen products and platelets, and the amount of blood transfusion of that

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The patients who are planned to perform Sonoclot guided blood transfusion

This study will be examined from preoperative days to the first postoperative day.

Interventions/Control_2

The patients who are planned to perform Sonoclot and TEG6s guided blood transfusion

This study will be examined from preoperative days to the first postoperative day.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

The patients who are planned to perform open heart surgery.

Key exclusion criteria

The patients who are difficult of mutual understanding and not be obtained consent

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Mitsutaka
Middle name
Last name Edanaga

Organization

Sapporo Medical University School of Medicine

Division name

Department of Anesthesiology

Zip code

060-8543

Address

S1, W16, Chuo-ku, Sapporo, Hokkaido, Japan

TEL

011-611-2111

Email

edanaka@sapmed.ac.jp


Public contact

Name of contact person

1st name Asami
Middle name
Last name Nakano

Organization

Sapporo Medical University School of Medicine

Division name

clinical study section of secretariat

Zip code

060-8543

Address

S1, W16, Chuo-ku, Sapporo, Hokkaido, Japan

TEL

011-611-2111

Homepage URL


Email

ke-rskk@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japanese Blood Products Organization

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo Medical University School of Medicine

Address

S1, W16, Chuo-ku, Sapporo, Hokkaido, Japan

Tel

011-611-2111

Email

ke-rskk@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 06 Month 08 Day

Date of IRB

2017 Year 06 Month 08 Day

Anticipated trial start date

2017 Year 07 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 06 Month 22 Day

Last modified on

2021 Year 06 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031933


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name